Percutaneous coronary intervention (PCI) of severe calcified lesions is at high risk
of complications (dissection, perforation, stent underexpansion, etc) and suboptimal
results have been associated with major cardiac adverse events. Intravascular lithotripsy
uses acoustic energy to disrupt the calcified plaque by creating microfractures. The
Shockwave C2 (Shockwave Medical Inc, Santa Clara, CA) intravascular lithotripsy system (S-IVL)
was approved by the Food and Drug Administration after studies confirming its safety
and efficacy.
1
,2
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Safety and effectiveness of coronary intravascular lithotripsy for treatment of severely calcified coronary stenoses: the Disrupt CAD II Study.Circ Cardiovasc Interv. 2019; 12e008434
- Intravascular lithotripsy for treatment of severely calcified coronary artery disease.J Am Coll Cardiol. 2020; 76: 2635-2646
- Intravascular lithotripsy in calcified coronary lesions: a prospective, observational, multicenter registry.Circ Cardiovasc Interv. 2019; 12e008154
Forero MT, Sardella G, Salvi N, et al. Coronary lithotripsy for the treatment of underexpanded stents; the international multicentre CRUNCH registry [e-pub ahead of print]. EuroIntervention doi:10.4244/EIJ-D-21-00545.
- IntravaScular Lithotripsy for the Management of UndILatable Coronary StEnt: the SMILE registry.Cardiovasc Revasc Med. 2020; 21: 1555-1559
Article Info
Publication History
Published online: May 25, 2022
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
© 2022 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
